Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.22 +0.47 (+3.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Dividends Paid - Common and Prefferd (2014)

Updated

Ultragenyx Pharmaceutical (RARE) recorded Dividends Paid - Common and Prefferd of $4.35 million in Q1 2014.

Analysis

Ultragenyx Pharmaceutical (RARE) Dividends Paid - Common and Prefferd (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div Paid (Total) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 1.55 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 3.23 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.07 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -2.87 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.36 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.03 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.45 Bn
10 Ultragenyx Pharmaceutical 1.50 Bn -302.56 Mn 180.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 4.35 Mn
API Access

Ultragenyx Pharmaceutical Dividends Paid - Common and Prefferd API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-paid-common-and-prefferd&ticker=RARE&period=max&api_key=YOUR_API_KEY